ICYMI: PhRMA COO Lori Reilly speaks about the health care agenda for the next Congress

With a divided Congress, bipartisan action will be necessary to move the needle on health care policy. On December 7, 2022, PhRMA sponsored the Axios event, “The Post-Midterm Health Care Agenda,” where I participated in a View from the Top segment with Nicholas Johnston, publisher of Axios. We discussed PhRMA’s focus on passing the PASTEUR Act in the last few weeks of 2022, and laid out PhRMA’s priorities heading into 2023 that will support and protect patients.

Polling shows that patients are concerned about the rising cost of health insurance premiums and what they are — or are not — receiving for that cost. That’s not a surprise when you consider that more than half of total spending on brand medicines went to the supply chain, middlemen and other stakeholders in 2020. As we look to the next Congress, we need bipartisan reforms that address the role insurers, pharmacy benefit managers (PBMs) and hospitals play in forcing patients to pay more for their medicine.

Patients deserve a health care system that works for them. We can protect their access to new treatments while improving patient affordability. Learn more here: PhRMA.org/Middlemen